nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—melanoma	0.515	1	CbGaD
Lumiracoxib—CYP1A2—Carmustine—melanoma	0.152	0.417	CbGbCtD
Lumiracoxib—CYP1A2—Vemurafenib—melanoma	0.12	0.33	CbGbCtD
Lumiracoxib—CYP1A2—Dacarbazine—melanoma	0.0918	0.253	CbGbCtD
Lumiracoxib—Diclofenac—CXCR1—melanoma	0.00479	0.403	CrCbGaD
Lumiracoxib—Tolmetin—CXCL8—melanoma	0.0022	0.185	CrCbGaD
Lumiracoxib—Diclofenac—CXCL8—melanoma	0.00121	0.102	CrCbGaD
Lumiracoxib—Bromfenac—PTGS2—melanoma	0.000953	0.0802	CrCbGaD
Lumiracoxib—Tolmetin—PTGS2—melanoma	0.00064	0.0539	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—melanoma	0.000631	0.0531	CrCbGaD
Lumiracoxib—Mefenamic acid—PTGS2—melanoma	0.000491	0.0413	CrCbGaD
Lumiracoxib—Diclofenac—PTGS2—melanoma	0.000353	0.0297	CrCbGaD
Lumiracoxib—Diclofenac—ALB—melanoma	0.000314	0.0265	CrCbGaD
Lumiracoxib—Diclofenac—ABCB1—melanoma	0.0003	0.0252	CrCbGaD
Lumiracoxib—CYP2C9—Metabolism—PLCB4—melanoma	3.84e-05	0.00035	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.78e-05	0.000345	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	3.77e-05	0.000344	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.77e-05	0.000343	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.75e-05	0.000342	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.74e-05	0.000341	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CD44—melanoma	3.72e-05	0.000339	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GNAQ—melanoma	3.72e-05	0.000339	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.65e-05	0.000332	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PLA2G6—melanoma	3.62e-05	0.00033	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIP4K2A—melanoma	3.61e-05	0.000329	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC6A11—melanoma	3.61e-05	0.000329	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.61e-05	0.000329	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP1B1—melanoma	3.57e-05	0.000325	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTAP—melanoma	3.52e-05	0.00032	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.49e-05	0.000318	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP17A1—melanoma	3.46e-05	0.000315	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.44e-05	0.000314	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PHGDH—melanoma	3.44e-05	0.000313	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—LUM—melanoma	3.44e-05	0.000313	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.44e-05	0.000313	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.41e-05	0.000311	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HPSE—melanoma	3.37e-05	0.000307	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	3.37e-05	0.000307	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.33e-05	0.000304	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CUBN—melanoma	3.31e-05	0.000301	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PLCB4—melanoma	3.28e-05	0.000299	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GNA11—melanoma	3.27e-05	0.000298	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—VCAN—melanoma	3.25e-05	0.000297	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	3.22e-05	0.000294	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—FASN—melanoma	3.2e-05	0.000291	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SDHD—melanoma	3.19e-05	0.000291	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BSG—melanoma	3.19e-05	0.000291	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CSPG4—melanoma	3.19e-05	0.000291	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.15e-05	0.000287	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SLC5A5—melanoma	3.14e-05	0.000286	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PHGDH—melanoma	3.13e-05	0.000286	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—LUM—melanoma	3.13e-05	0.000286	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—GAB2—melanoma	3.1e-05	0.000282	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GPAM—melanoma	3.09e-05	0.000282	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC6A11—melanoma	3.09e-05	0.000281	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIP4K2A—melanoma	3.09e-05	0.000281	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.08e-05	0.000281	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HPSE—melanoma	3.07e-05	0.00028	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CD44—melanoma	3.04e-05	0.000277	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GNAQ—melanoma	3.04e-05	0.000277	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FASN—melanoma	3.03e-05	0.000276	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CUBN—melanoma	3.02e-05	0.000275	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTAP—melanoma	3e-05	0.000274	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.97e-05	0.000271	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.97e-05	0.000271	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.95e-05	0.000268	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ABCB1—melanoma	2.94e-05	0.000268	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.94e-05	0.000268	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SDHD—melanoma	2.91e-05	0.000265	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CSPG4—melanoma	2.91e-05	0.000265	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BSG—melanoma	2.91e-05	0.000265	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP1B1—melanoma	2.91e-05	0.000265	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CXCR4—melanoma	2.91e-05	0.000265	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HDAC2—melanoma	2.91e-05	0.000265	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FOXO4—melanoma	2.91e-05	0.000265	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD44—melanoma	2.88e-05	0.000262	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GPAM—melanoma	2.82e-05	0.000257	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.81e-05	0.000256	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP17A1—melanoma	2.74e-05	0.00025	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.71e-05	0.000247	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PRKCA—melanoma	2.71e-05	0.000247	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ERCC2—melanoma	2.68e-05	0.000245	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PHGDH—melanoma	2.68e-05	0.000244	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LUM—melanoma	2.68e-05	0.000244	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.67e-05	0.000244	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT3—melanoma	2.66e-05	0.000242	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PLA2G6—melanoma	2.63e-05	0.00024	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HPSE—melanoma	2.63e-05	0.000239	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GNA11—melanoma	2.59e-05	0.000236	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CUBN—melanoma	2.58e-05	0.000235	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.57e-05	0.000234	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—FASN—melanoma	2.54e-05	0.000231	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC5A5—melanoma	2.5e-05	0.000227	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SDHD—melanoma	2.49e-05	0.000227	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BSG—melanoma	2.49e-05	0.000227	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CSPG4—melanoma	2.49e-05	0.000227	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GPAM—melanoma	2.41e-05	0.00022	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GNAQ—melanoma	2.41e-05	0.00022	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CD44—melanoma	2.41e-05	0.00022	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PLA2G6—melanoma	2.4e-05	0.000219	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ABCB1—melanoma	2.4e-05	0.000218	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—VCAN—melanoma	2.36e-05	0.000215	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.36e-05	0.000215	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB4—melanoma	2.35e-05	0.000214	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN2B—melanoma	2.33e-05	0.000212	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP1B1—melanoma	2.31e-05	0.000211	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD86—melanoma	2.25e-05	0.000205	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.24e-05	0.000204	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.22e-05	0.000203	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PRKCA—melanoma	2.21e-05	0.000201	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ERCC2—melanoma	2.19e-05	0.000199	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGF1—melanoma	2.18e-05	0.000199	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.16e-05	0.000197	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—VCAN—melanoma	2.15e-05	0.000196	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CG—melanoma	2.12e-05	0.000193	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PDGFRA—melanoma	2.11e-05	0.000192	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PRKCA—melanoma	2.09e-05	0.000191	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERCC2—melanoma	2.07e-05	0.000189	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PLA2G6—melanoma	2.05e-05	0.000187	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARG—melanoma	2.05e-05	0.000186	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAP2K2—melanoma	2.04e-05	0.000186	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.04e-05	0.000186	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.04e-05	0.000186	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP17A1—melanoma	1.99e-05	0.000182	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.97e-05	0.000179	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.97e-05	0.000179	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TERT—melanoma	1.94e-05	0.000177	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HLA-A—melanoma	1.94e-05	0.000177	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.94e-05	0.000177	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RAC1—melanoma	1.94e-05	0.000177	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ABCB1—melanoma	1.9e-05	0.000173	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GNA11—melanoma	1.88e-05	0.000172	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CD—melanoma	1.86e-05	0.00017	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HIF1A—melanoma	1.86e-05	0.000169	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—FASN—melanoma	1.84e-05	0.000168	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—VCAN—melanoma	1.84e-05	0.000168	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—melanoma	1.84e-05	0.000168	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP17A1—melanoma	1.82e-05	0.000166	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC5A5—melanoma	1.81e-05	0.000165	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.81e-05	0.000165	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.79e-05	0.000163	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.77e-05	0.000161	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PRKCA—melanoma	1.75e-05	0.00016	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CD44—melanoma	1.75e-05	0.00016	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GNAQ—melanoma	1.75e-05	0.00016	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.74e-05	0.000159	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ERCC2—melanoma	1.74e-05	0.000158	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CG—melanoma	1.73e-05	0.000157	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GNA11—melanoma	1.72e-05	0.000156	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.71e-05	0.000156	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.7e-05	0.000155	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS2—melanoma	1.69e-05	0.000154	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.68e-05	0.000153	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—FASN—melanoma	1.68e-05	0.000153	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP1B1—melanoma	1.68e-05	0.000153	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOTCH1—melanoma	1.67e-05	0.000153	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARG—melanoma	1.67e-05	0.000152	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC5A5—melanoma	1.65e-05	0.000151	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD80—melanoma	1.64e-05	0.00015	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APC—melanoma	1.64e-05	0.000149	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KIT—melanoma	1.64e-05	0.000149	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CB—melanoma	1.62e-05	0.000148	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGF—melanoma	1.62e-05	0.000148	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—melanoma	1.61e-05	0.000147	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GNAQ—melanoma	1.6e-05	0.000145	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CD44—melanoma	1.6e-05	0.000145	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.56e-05	0.000142	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP17A1—melanoma	1.55e-05	0.000142	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.55e-05	0.000141	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BRAF—melanoma	1.54e-05	0.00014	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.53e-05	0.00014	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP1B1—melanoma	1.53e-05	0.000139	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CD—melanoma	1.52e-05	0.000138	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.51e-05	0.000138	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—melanoma	1.5e-05	0.000137	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.48e-05	0.000135	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GNA11—melanoma	1.47e-05	0.000134	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAP2K1—melanoma	1.45e-05	0.000132	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CD—melanoma	1.44e-05	0.000131	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.44e-05	0.000131	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—FASN—melanoma	1.44e-05	0.000131	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC5A5—melanoma	1.41e-05	0.000129	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—melanoma	1.4e-05	0.000128	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ABCB1—melanoma	1.38e-05	0.000126	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGF2—melanoma	1.38e-05	0.000126	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CG—melanoma	1.37e-05	0.000125	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GNAQ—melanoma	1.36e-05	0.000124	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CD44—melanoma	1.36e-05	0.000124	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.35e-05	0.000123	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.34e-05	0.000122	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CB—melanoma	1.32e-05	0.000121	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARG—melanoma	1.32e-05	0.000121	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.32e-05	0.000121	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—melanoma	1.31e-05	0.00012	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP1B1—melanoma	1.31e-05	0.000119	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MDM2—melanoma	1.29e-05	0.000118	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PRKCA—melanoma	1.27e-05	0.000116	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB2—melanoma	1.27e-05	0.000116	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ERCC2—melanoma	1.26e-05	0.000115	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCB1—melanoma	1.26e-05	0.000115	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CB—melanoma	1.25e-05	0.000114	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—melanoma	1.25e-05	0.000114	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CD—melanoma	1.21e-05	0.00011	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—melanoma	1.19e-05	0.000108	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1B—melanoma	1.18e-05	0.000107	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PRKCA—melanoma	1.16e-05	0.000106	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.15e-05	0.000105	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ERCC2—melanoma	1.15e-05	0.000105	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—melanoma	1.14e-05	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CTNNB1—melanoma	1.11e-05	0.000101	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1A—melanoma	1.09e-05	9.91e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—melanoma	1.08e-05	9.88e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCB1—melanoma	1.08e-05	9.81e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CB—melanoma	1.05e-05	9.58e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.04e-05	9.52e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CG—melanoma	9.96e-06	9.08e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PRKCA—melanoma	9.91e-06	9.03e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CA—melanoma	9.9e-06	9.02e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ERCC2—melanoma	9.83e-06	8.96e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT3—melanoma	9.7e-06	8.84e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NRAS—melanoma	9.67e-06	8.82e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARG—melanoma	9.61e-06	8.76e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.53e-06	8.68e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAPK3—melanoma	9.26e-06	8.44e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CG—melanoma	9.08e-06	8.28e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—melanoma	9.08e-06	8.28e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MYC—melanoma	9.01e-06	8.21e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAPK1—melanoma	8.82e-06	8.03e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGFR—melanoma	8.81e-06	8.03e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARG—melanoma	8.77e-06	7.99e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CD—melanoma	8.76e-06	7.98e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—melanoma	8.64e-06	7.88e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KRAS—melanoma	8.33e-06	7.59e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.14e-06	7.42e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKT1—melanoma	8.09e-06	7.37e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CA—melanoma	8.07e-06	7.36e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CD—melanoma	7.98e-06	7.28e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—melanoma	7.88e-06	7.18e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CG—melanoma	7.76e-06	7.07e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CA—melanoma	7.65e-06	6.97e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CB—melanoma	7.63e-06	6.96e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—melanoma	7.56e-06	6.89e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARG—melanoma	7.49e-06	6.83e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HRAS—melanoma	7.08e-06	6.45e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CB—melanoma	6.96e-06	6.34e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—melanoma	6.9e-06	6.28e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CD—melanoma	6.82e-06	6.22e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—melanoma	6.77e-06	6.17e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—melanoma	6.74e-06	6.14e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—melanoma	6.6e-06	6.01e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—melanoma	6.59e-06	6.01e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CA—melanoma	6.41e-06	5.84e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—melanoma	6.25e-06	5.7e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—melanoma	6.01e-06	5.48e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CB—melanoma	5.95e-06	5.42e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—melanoma	5.89e-06	5.37e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—melanoma	5.23e-06	4.77e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—melanoma	5.14e-06	4.68e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CA—melanoma	4.65e-06	4.24e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CA—melanoma	4.24e-06	3.87e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—melanoma	3.8e-06	3.46e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CA—melanoma	3.63e-06	3.3e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—melanoma	3.47e-06	3.16e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—melanoma	2.96e-06	2.7e-05	CbGpPWpGaD
